Discovery of New Immune Checkpoints: Family Grows Up

Kong, X

Kong, X (corresponding author), Bristol Myers Squibb Global Clin Res, Shanghai, Peoples R China.

REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY, 2020; 1248 (): 61

Abstract

The first generation of immune checkpoint inhibitors (ICIs) including anti-CTLA-4 and anti-PD-1/anti-PD-L1 has achieved profound and great success. Ti......

Full Text Link